Amagma, Inc. announced it raised $2.28 Million in an initial filing from an offering of $2.28 Million
Amagma, Inc. announced it raised $2.28 Million in an initial filing from an offering of $2.28 Million
06/01/22, 6:54 PM
Location
Money raised
$2.28 million
Industry
biotechnology
Round Type
seed
Company Info
Location
100 beaver street
waltham, massachusetts, united states
Additional Info
Amagma Therapeutics is a startup biotechnology company founded by proven serial entrepreneurs including Prof. Tillman Gerngross and Prof. Leonard Zon. Amagma scientists are working on the discovery and development of antibody therapeutics against inflammatory diseases (with a focus on GI disorders) which have proven intractable by other approaches. Amagma is based in Waltham, Massachusetts, and funded by private investors including Polaris Partners.